Medical Devices Startups
6,125 companies tagged Medical Devices, with their investors and founders.
EOS imaging provides low-dose 2D/3D imaging systems and software solutions for orthopedic surgery, enabling surgical planning and post-operative assessment. The company serves orthopedic surgeons and healthcare providers across more than 40 countries.
2 investors
EPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.
2 investors
Epidarex is a venture capital firm that invests equity in early-stage life science and health technology companies, particularly university spin-outs and startups in under-ventured research hubs across the UK and US. The firm leverages its network of scientists, industry executives, and regulatory experts to support portfolio companies in translating research into commercial healthcare businesses.
2 investors
Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.
2 investors
Epion Therapeutics is developing EpiSmart, a minimally-invasive corneal cross-linking system to treat keratoconus and corneal ectasia without disrupting the epithelium. The treatment targets patients with ectatic corneal disease as an early-intervention standard of care.
2 investors
Epitomee develops ingestible therapeutic devices and platforms that deliver targeted therapies along the gastrointestinal tract to manage metabolic diseases, obesity, and deliver biologics. The company combines mechanical and ingestible morphology platforms with therapeutic agents to achieve specific localization with limited side effects.
2 investors
Epsilon partners radiologists with advanced technology to address the radiology shortage in the US and improve diagnostic accuracy and speed. The company combines human expertise with AI to reduce delays in medical imaging, which accounts for 75% of medical decisions.
2 investors
Epsilon Imaging develops EchoInsight, a software platform that uses speckle-tracking strain imaging and automated analysis to detect cardiovascular dysfunction from echocardiograms earlier than traditional methods. The platform combines AI-driven automation with engineered algorithms to help clinicians assess heart function, monitor disease progression, and support clinical decision-making.
2 investors
Clario provides endpoint technologies and software for clinical trial management, serving pharmaceutical and biotech sponsors, CROs, and clinical trial sites globally. The platform combines imaging analysis, electronic clinical outcome assessments, cardiac safety monitoring, and AI-powered solutions to support site-based, hybrid, and decentralized clinical trials.
2 investors
eSight makes a wearable, hands-free digital device that uses a camera and image-processing algorithms to enhance sight for people with central vision loss and legal blindness caused by more than 20 eye conditions. The product offers features such as zoom, contrast, and color filters to help users read, recognize faces, watch TV, and maintain mobility, and it includes a personal coaching program for setup and support.
2 investors
EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.
2 investors
Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.
2 investors
Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning. Its work targets continuous physiological monitoring, including blood pressure sensing, for healthcare applications.
2 investors
Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.
2 investors
Ethicon develops surgical products and technologies including wound closure, hemostats, surgical stapling, surgical energy, antimicrobial dressings, and surgical instruments, along with clinical education programs for surgeons. Part of Johnson & Johnson MedTech, it serves clinicians and healthcare providers across specialties such as bariatric, cardiovascular, colorectal, gynecology, orthopaedic, and thoracic surgery.
2 investors
EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions. The company positions itself as a provider of comprehensive, research-driven solutions to CGT challenges.
2 investors
Evolve Biosystems develops probiotic strains of B. infantis, including EVC001 and a next-generation drug strain INF108, aimed at supporting the infant gut microbiome and preventing necrotizing enterocolitis (NEC) in premature infants. The company works at the intersection of breast milk research and infant health in the biotech and digital/medical therapeutics space.
2 investors
Exact Sciences develops diagnostic tests for cancer, including tests that assess hereditary risk, screen for the presence of cancer, and analyze the genomic alterations of a diagnosed cancer to inform treatment decisions. Its products serve patients and clinicians in oncology diagnostics.
2 investors
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.
2 investors
Exero Medical develops the xBar system, which uses electrode sensors embedded in a standard surgical drain to non-invasively monitor post-operative tissue healing and detect anastomotic leaks after gastrointestinal surgery. The system provides healthcare providers with post-operative data to enable earlier detection of complications; it is currently limited to investigational use in the US.
2 investors
Eximis Surgical develops a minimally invasive specimen removal device for use in abdominal surgery, enabling surgeons to remove surgical specimens through small incisions rather than requiring larger incisions at the end of procedures. The device targets patients undergoing minimally invasive surgical procedures to reduce postoperative pain and recovery time.
2 investors
EXOKΔRYX develops semiconductor-based technology for isolation, characterization, and analysis of extracellular vesicles to enable earlier disease and cancer detection in research settings. The company serves biomedical researchers working on disease detection and diagnostics using chip-based sensors and dielectrophoresis technology.
2 investors
Exostemtech develops exosome-based therapeutics using platform technologies derived from adult stem cells for treating diseases including osteoarthritis, obesity, diabetes, fatty liver disease, and fibrosis. The company operates in the biotechnology and therapeutic drug development sector.
2 investors
Eyas Medical Imaging develops MRI technology designed specifically for imaging babies and infants. The company serves healthcare professionals and hospitals seeking precision imaging solutions for neonatal and pediatric patients.
2 investors